| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |